healthcare News
Aetna Endorses AI Imaging, Boosting Medical Diagnostics Sector
Insurer's approval for Cleerly's heart disease analysis marks a critical step towards broader insurance reimbursement for AI-driven diagnostic tools, signaling a major commercial milestone.
Vaccine Makers Face Headwinds as US Cuts Childhood Shot Schedule
Merck and GSK's pediatric franchises under pressure after health officials moved key immunizations, including for HPV and meningitis, from the universally recommended list.
Modivcare Exits Bankruptcy as Private Firm, Slashes Debt by $1.1 Billion
Healthcare logistics provider completes swift restructuring, ends public trading, and secures $100 million in fresh capital from its new owners.
Organogenesis Dips 10% on Misread of Medicare Ruling
Shares fall as investors focus on short-term uncertainty, while analysts see a long-term positive in the overhauled skin-graft reimbursement rules.
Pfizer Shares Fall After Patient Death in Hemophilia Drug Study
A patient with hemophilia A died from a stroke, prompting a safety review of the marstacimab trial. The company does not foresee an impact on the approved version of the drug.
Pharma Giants Cut Drug Prices in Deal with Trump for Tariff Relief
Merck, Gilead, and others accept significant discounts on key medicines in exchange for tariff exemptions and regulatory clarity, boosting US manufacturing.
Bristol Myers Jumps After US Drug Pricing Deal Removes Key Overhang
Company to provide blockbuster Eliquis free to some patients, securing a three-year exemption from tariffs and future pricing mandates in a strategic win.
Novartis Climbs Near 52-Week High on US Drug Price and Tariff Deal
Swiss drugmaker strikes accord offering pricing concessions and a $23B investment in exchange for tariff relief, signaling a new phase of government-pharma collaboration.